Most Healthcare AI Is Priced Like Software
Look at how most healthcare AI vendors charge and you will see the same models: per seat, per agent, per user, per module. Those models are borrowed from SaaS. They measure how much software you use, not what that software does for your business.
For a multi-site DSO or MSO, that is the wrong unit of value. A private equity sponsor does not underwrite a platform on how many AI agents it licenses. It underwrites EBITDA, margin, and the multiple it can realize at exit. Seat-based pricing leaves the operator to carry all the risk of whether the tool actually moves those numbers.
Samara takes a different approach. Samara is priced on outcomes.
The 3 Outcomes Samara Is Built to Drive
Samara is purpose-built to drive three kinds of customer outcomes. Each one feeds the next: a better patient experience drives operational performance, and operational performance drives business value.
1. Business Outcomes
- EBITDA expansion at the location and platform level
- Margin expansion from higher revenue per location on the same fixed cost base
- OpEx compression by taking repetitive front-office work off staff
- ROIC protection on every acquisition, so newly added locations earn their purchase price
- Stronger exit multiples from standardized, measurable, scalable operations
2. Operational Outcomes
- Higher appointment fill rates across every provider and chair
- Fewer no-shows through proactive confirmation and smart rebooking
- Stronger Google and ChatGPT visibility, so new patients find each location in search and in AI answer engines
- Better reviews that compound into more new-patient demand
3. Patient Outcomes
- Higher NPS across the patient journey
- One-touch scheduling, so booking takes seconds rather than a phone tag cycle
- Easier appointment coordination for reminders, reschedules, and follow-ups
What We Charge, and What We Are Accountable For
Samara's pricing is simple: $50K per location, per year.
Our bar is equally simple: $50K+ of added EBITDA per location, after our fee. In other words, each location should generate at least $100K of incremental EBITDA before Samara's cost, so the net gain to the business is at least $50K per location.
The Enterprise Value Math
For a PE-backed platform, EBITDA is only half the story. Every incremental dollar of EBITDA is capitalized at exit.
At a 6x exit multiple, $50K of added EBITDA per location equals $300K of enterprise value created per location.
Here is how that scales across a portfolio:
| Locations | Added EBITDA (after fee) | Enterprise Value at 6x |
|---|---|---|
| 1 | $50K | $300K |
| 4 | $200K | $1.2M |
| 10 | $500K | $3.0M |
| 25 | $1.25M | $7.5M |
A 4-location group adds $200K of EBITDA and $1.2M of enterprise value. That is what Samara is accountable for.
Not Features. Outcomes.
Feature lists are easy to compare and hard to cash. A platform can ship an AI receptionist, an AI scheduler, and a reputation tool and still leave a location's P&L unchanged. Outcome-based pricing forces a different conversation: which locations are underperforming, why, and what it will take to close the gap.
That is how Samara works with DSOs and MSOs. We start with location-level performance, identify what is holding each location back, and deploy the AI workforce against those specific constraints: unfilled schedule capacity, no-shows, weak search and AI visibility, thin review volume, or front-office cost. For more on how this plays out across a portfolio, see our guide to how private equity uses AI to expand EBITDA in healthcare portfolios.
A Question for Multi-Site DSO and MSO Operators
If you run a multi-site DSO or MSO, ask yourself two questions:
- Do you know what each location is worth today?
- Do you know what is holding the weakest one back?
If the answer to either is "not exactly," that is where Samara starts. Book a demo to see a location-by-location view of where the EBITDA is, or explore our private equity and DSO pages.
FAQs: Outcome-Based Pricing for Healthcare AI
What is outcome-based pricing in healthcare AI?
Outcome-based pricing ties what a vendor charges to the business results it delivers, rather than to seats, users, or agents. Samara charges $50K per location per year and holds itself to a bar of $50K+ of added EBITDA per location after that fee.
How much does Samara cost per location?
Samara costs $50K per location, per year, for multi-site DSOs and MSOs.
How does added EBITDA translate into enterprise value?
Enterprise value is typically calculated as EBITDA multiplied by an exit multiple. At 6x, every $50K of added EBITDA creates $300K of enterprise value. Across 4 locations, $200K of added EBITDA creates $1.2M of enterprise value.
Who is outcome-based pricing designed for?
It is designed for multi-site DSOs, MSOs, and PE-backed outpatient platforms that measure success in EBITDA, margin, and exit multiples rather than software usage.